Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Lymphatic Metastasis 1Liver Neoplasms 1Keratosis, Actinic 1Gallbladder Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma, Basal Cell 1Carcinoma 1Biliary Tract Neoplasms 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 86atezolizumab 80pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 44Radiofrequency Ablation 44Hepatectomy 43Leucovorin 41camrelizumab 40Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28Gemcitabine 26Cyclophosphamide 26cabozantinib 25Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Methylation × Clear all
NCT04445532 2023-07-07

Hepatobiliary Tumors Tissue Samples Acquisition

Peking Union Medical College Hospital

Unknown
450 enrolled
GastrointestinalOther neoplasm

Biliary Tract Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Precancerous Conditions, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡